Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells

Biotechnology and Bioengineering

Volumn 59, Issue 5, 1998, Pages 567-575

  Côté, Johanne ^a   Garnier, Alain ^a,b   Massie, Bernard ^a   Kamen, Amine ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

293 cells; Adenoviral vectors; Adenovirus; Recombinant proteins; Serum free medium

Indexed keywords

BIOREACTORS; ENZYMES; VIRUSES;

ADENOVIRUS;

CLONING;

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL CULTURE; GENE TECHNOLOGY; HUMAN; HUMAN CELL; MOLECULAR CLONING; PROTEIN SYNTHESIS;

ADENOVIRIDAE; BETA-GALACTOSIDASE; BIOREACTORS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CULTURE MEDIA, SERUM-FREE; GENETIC VECTORS; GLUCOSE; HELA CELLS; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; TIME FACTORS;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

EID: 2642647059     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19980905)59:5<567::AID-BIT6>3.0.CO;2-8     Document Type: Article

References (20)

1. Acsadi, G., Jani, A., Massie, B., Simoneau, M., Holland, P., Blaschuk, K., Karpati, G. 1994. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3: 579-584.
2. Acsadi, G., Massie, B., Jani, A. 1995. Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73: 165-180.
3. Berg, D. T., McClure, D. B., Grinnell, B. W. 1993. High-level expression of secreted proteins from cells adapted to serum-free suspension culture. BioTechniques 14(6): 972-978.
4. Côté, J., Bourget, L., Garnier, A., Kamen, A. 1997. Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring. Biotechnol. Prog. 13: 709-714.
5. Gamier, A., Côté, J., Nadeau, I., Kamen, A., Massie B. 1994. Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnol. 15: 145-155.
6. Graham, F. L., Smiley, J., Russel, W. C., Nairn, R. 1977. Characteristics of human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36: 59-72.
7. Grimaux, M., Lainé-Bidron, C., Magdelénat, H. 1989. Immunoenzymetric assay of epidermal growth factor receptor - Application to breast cancer samples. Tumor Biol. 10: 215-224.
8. Jani, A., Lochmüller, H., Acsadi, G., Simoneau, M., Huard, J., Garnier, A., Karpati, G., Massie, B. 1997. Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human distrophin cDNA. J. Virol. 64: 111-124.
9. Jayme, D., Watanabe, T., Shimada, T. 1997. Basal medium development for serum-free culture: A historical perspective. Cytotechnol. 23: 95-101.
10. Kamen, A. A., Tom, R. L., Caron, A. W., Chavarie, C., Massie, B., Archambault, J. 1991. Culture of insect cells in a helical ribbon impeller bioreactor. Biotechnol. Bioeng. 38: 619-628.
11. Male, K. B., Gartu, P.O., Kamen, A.A., Luong, J. H. T. 1997. Online monitoring of glucose in mammalian cell cultrure using a flow injection analysis (FIA) mediated biosensor. Biotechnol. Bioeng. 55: 497-504.
12. Massie, B., Dionne, J., Lamarche, N., Fleurent, J., Langelier, Y. 1995. Improved adenovirus vector produces herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Bio/Technology 13: 602-608.
13. Mittereder, N., March, K. L., Trapnell, B. C. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70: 7498-7509.
14. Nadeau, I., Garnier, A., Côté, J., Massie, B., Chavarie, C., Kamen, A. 1996. Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol. Bioeng. 51: 613-623.
15. Persson, R., Svensson, U., Everitt, E. 1983. Virus receptor in the adenovirus system. II Caping and cooperative binding of virions on HeLa cells. J. Virol. 46: 956-963.
16. Peshwa, M. V., Kyung, Y.-S., McClure, D. B., Hu, W.-S. 1993. Cultivation of mammalian cells as aggregates in bioreactors; Effect of calcium concentration on spatial distribution of viability. Biotechnol. Bioeng. 41: 179-187.
17. Stratford-Perricaudet, L. D., Perricaudet, M. 1994. Gene therapy: The advent of adenovirus, pp. 344-362. In: J. A. Wolff (ed.), Gene therapeutics: Methods and applications. Birkhäuser, Boston.
18. Trapnell, B. C., Gorzilia, M. 1994. Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5: 617-625.
19. Wickham, T. J., Davis, T., Granados, R. R., Shuler, M. L., Wood, H. A. 1992. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotech. Prog. 8: 391-396.
20. Zhai, Y., Yang, J. C., Kawakami, Y., Spiess, P., Wadsworth, S. C., Cardoza, L. M., Couture, L. A., Smith, A. E., Rosenberg, A. 1996. Antigen-specific tumor vaccines - Development and characterization of recombinant adenoviruses encoding MARTI or gp100 for cancer therapy. J. Immunol. 156: 700-710.